Citadel Advisors - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H901. A total of 2 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$310,000
-62.1%
33,600
-64.2%
0.00%
-100.0%
Q1 2016$818,000
+840.2%
93,900
+622.3%
0.00%
Q4 2015$87,000
-20.9%
13,000
-31.6%
0.00%
Q3 2015$110,000
-38.5%
19,000
-13.2%
0.00%
Q2 2015$179,000
-12.7%
21,900
-12.7%
0.00%
Q1 2015$205,000
-10.5%
25,100
+0.8%
0.00%
Q4 2014$229,000
-41.7%
24,900
-37.6%
0.00%
Q3 2014$393,000
+14.6%
39,900
+25.9%
0.00%
Q2 2014$343,00031,7000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 129$114,0000.02%
GROUP ONE TRADING, L.P. 615,400$5,446,0000.01%
IMC-Chicago, LLC 492,600$4,360,0000.01%
SIMPLEX TRADING, LLC 4,387$3,882,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders